Medical ghostwriter

Last updated

Medical ghostwriters are employed by pharmaceutical companies and medical-device manufacturers to produce apparently independent manuscripts for peer-reviewed journals, conference presentations and other communications. Physicians and other scientists are paid to attach their names to the manuscripts as though they had authored them. The named authors may have had little or no involvement in the research or writing process. [1]

Contents

Definitions and rules

The American Medical Writers Association speaks to the topic as follows: [2]

"Ghost authoring" refers to making substantial contributions without being identified as an author. "Guest authoring" refers to being named as an author without having made substantial contributions. "Ghostwriting" refers to assisting in presenting the author's work without being acknowledged. The term "ghostwriting" is often used to encompass all three of these practices.

The rules for authorship and contribution of the International Committee of Medical Journal Editors (ICMJE, informally known as "the Vancouver Group" from the locale of the group's first meeting, Vancouver, British Columbia, Canada) are a single, universally-respected set of guidelines for describing authorship of and contribution to professional medical publications. The document "International Committee of Medical Journal Editors: Defining the Role of Authors and Contributors" [3] is considered the definitive statement of ethical requirements for how authorship in medical journal articles (the prime forum for medical professional publication) and the degree to which a given writer is deemed to have contributed to the content of a medical journal article are determined. Compliance with the International Committee of Medical Journal Editors' Uniform Requirements for Manuscripts Submitted to Biomedical Journals [4] is voluntary. A list of medical journals which have stated that they follow the Uniform Requirements for Manuscripts Submitted to Biomedical Journals [5] is maintained by the International Committee of Medical Journal Editors.

How closely individual medical journals and authors of medical journal articles comply with ICMJE guidelines is a largely self-policed matter. The ICMJE document "Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Publishing and Editorial Issues Related to Publication in Biomedical Journals: Corrections, Retractions and "Expressions of Concern" [6] is the section of the ICMJE Uniform Requirements laying out guidelines for how potential or actual scientific error and scientific fraud ought to be dealt with. It refers readers to the relevant guidelines from the Committee for Publication Ethics (COPE) [7] - specifically COPE's flowcharts outlining a systematic approach toward scientific error and possible fraud. [8]

Criticism

Medical ghostwriting has been criticized by a variety of professional organizations [9] [10] representing the drug industry, publishers, and medical societies, and it may violate American laws prohibiting off-label promotion by drug manufacturers as well as anti-kickback provisions within the statutes governing Medicare. [11] Recently, it has attracted scrutiny from the lay press [12] [13] lawmakers [14] the Institute of Medicine, [15] and the National Institutes of Health. [16] as well. It is permitted at some institutions[ clarify ], including the University of Washington School of Medicine, [17] [ failed verification ] [18] [ verification needed ] while it is prohibited and considered a particularly pernicious form of plagiarism at others, such as Tufts University School of Medicine and the University of Pennsylvania School of Medicine. [15] [19]

Scandals involving prominent physicians researchers have been reported at over a dozen universities in the United States, however, there have been no reports of any professors being disciplined. [15] Professor Trudo Lemmens of the University of Toronto Faculty of Law argues that ghostwritten papers help protect companies when they are sued in court. [20]

Perhaps the most pernicious practice in ghostwriting involves thanking writers for providing “editorial assistance” in the acknowledgments section of the paper instead of the authorship byline, which essentially changes the rule of authorship attribution so that ghostwriting is acceptable. Several groups in medicine including the European Medical Writers Association (EMWA) sanction this practice. While the average reader likely interprets “editorial assistance” as help with grammar or improvements to the overall readability of the article, in reality, such “assistants” make major contributions to papers, and would commonsensically be considered co-authors. Tellingly, many medical writers are “editorial assistants” on some scientific papers, but co-authors on others. It would seem obvious that someone employed as a “medical writer” would be an author, but current dialogue on ghostwriting ignores such common-sense interpretations. Listing ghost authors as editorial assistants allows pharmaceutical companies to publish articles with conflicts-of interest that are not transparently reported. Editorial assistants are not mentioned in the abstract, are not indexed in publication databases, are not mentioned in subsequent citations, and are never mentioned in news media accounts of the article. In other words, the fact that a pharmaceutical company directly co-authored the paper is concealed from view. That this is seen as acceptable in an era of increased disclosure of conflicts-of-interest is puzzling.

While several groups in medicine including the European Medical Writers Association (EMWA) sanction the practice of thanking medical writers for providing “editorial assistance” in the acknowledgments section of the paper instead of listing them on the authorship byline, the problem with simply thanking ghostwriters in the acknowledgements section is clearly illustrated by Study 329, probably the most notorious ghostwritten paper in the medical literature. The study examined the use of Paxil in adolescents and concluded, “Paroxetine is generally well tolerated and effective for major depression in adolescents.” Several years after the paper was published, court proceedings revealed internal company documents admitting that the study found that Paxil was not any better than placebo on the pre-registered outcome measures, and that the company was concerned about how to manage the negative findings. According to the revised ICMJE Guidelines, Professional medical writers who write papers are not exempt from being listed as authors of the paper [21]

Prevalence

It is difficult to determine how frequently ghostwriting occurs due to its covert nature. A 2009 New York Times article estimated that 11% of New England Journal of Medicine articles, 8% of JAMA , Lancet and PLoS Medicine articles, 5% of Annals of Internal Medicine articles and 2% of Nature Medicine were ghost written. [22] Between 1998 and 2005 Wyeth had 26 papers promoting hormone replacement therapy (HRT) published in scientific journals. [23]

Previously secret internal Wyeth documents providing evidence of this are viewable on the Drug Industry Document Archive. It also appears to have occurred in 75% of industry funded trials between 1994 - 1995 approved by the Scientific Ethical Committees for Copenhagen and Frederiksberg. [1] Of the articles published from 1998 to 2000 regarding sertraline, between 18% and 40% were ghost written by Pfizer. [1] A questionnaire using comparable methods in 2005 and 2008 with a 14-28% response rate found a decrease in number of people who reported ghostwriting among professional medical writers. [24]

Most pharmaceutical companies have in-house publication managers who may either manage the writing of publications on the company's drugs by a team of in-house medical writers or contract them out to medical communication companies or freelance medical writers. Reprints of the articles can be distributed to doctors in their offices or at medical meetings by drug company representatives in lieu of product brochures. This practice might be illegal if it effectively constitutes advertising or advocating use of the drug for non-approved indications or dosages. Payments to medical ghostwriters may be augmented with consulting contracts, paid trips to teach continuing medical education courses, or grants. The academics or doctors are known as "KOLs" ("Key Opinion Leaders") or "TLs" ("Thought Leaders"). [25]

Senate investigation

On June 24, 2010, Senator Charles E. Grassley, Ranking Member of the United States Senate Committee on Finance issued a report on medical ghost writing. The report said, "The Committee was provided with documents from recent lawsuits involving Wyeth’s hormone therapy products. The documents showed that Wyeth hired a medical communications and education company, DesignWrite Inc. (DesignWrite), to draft review articles regarding the breast cancer risk of hormone therapy products and then invited academic researchers to sign on as the primary authors." [26]

See also

Related Research Articles

Scientific misconduct is the violation of the standard codes of scholarly conduct and ethical behavior in the publication of professional scientific research.

<span class="mw-page-title-main">Preprint</span> Academic paper prior to journal publication

In academic publishing, a preprint is a version of a scholarly or scientific paper that precedes formal peer review and publication in a peer-reviewed scholarly or scientific journal. The preprint may be available, often as a non-typeset version available free, before or after a paper is published in a journal.

<span class="mw-page-title-main">Ghostwriter</span> Writer who writes for the credited author

A ghostwriter is a person hired to write literary or journalistic works, speeches, or other texts that are putatively credited to another person as the author. Celebrities, executives, participants in timely news stories, and political leaders often hire ghostwriters to draft or edit autobiographies, memoirs, magazine articles, or other written material.

<span class="mw-page-title-main">Scientific literature</span> Literary genre

Scientific literature comprises academic papers that report original empirical and theoretical work in the natural and social sciences. Within a field of research, relevant papers are often referred to as "the literature". Academic publishing is the process of contributing the results of one's research into the literature, which often requires a peer-review process.

In scientific writing, IMRAD or IMRaD is a common organizational structure. IMRaD is the most prominent norm for the structure of a scientific journal article of the original research type.

<span class="mw-page-title-main">David Healy (psychiatrist)</span> Irish-born pharmacologist

David HealyFRCPsych, a professor of psychiatry at Bangor University in the United Kingdom, is a psychiatrist, psychopharmacologist, scientist and author. His main areas of research are the contribution of antidepressants to suicide, conflict of interest between pharmaceutical companies and academic medicine, and the history of pharmacology. Healy has written more than 150 peer-reviewed articles, 200 other articles, and 20 books, including The Antidepressant Era, The Creation of Psychopharmacology, The Psychopharmacologists Volumes 1–3, Let Them Eat Prozac and Mania: A Short History of Bipolar Disorder.

<i>PLOS Medicine</i> Academic journal

PLOS Medicine is a peer-reviewed weekly medical journal covering the full spectrum of the medical sciences. It began operation on October 19, 2004, as the second journal of the Public Library of Science (PLOS), a non-profit open access publisher. All content in PLOS Medicine is published under the Creative Commons "by-attribution" license. To fund the journal, the publication's business model requires in most cases that authors pay publication fees. The journal was published online and in a printed format until 2005 and is now only published online. The journal's acting chief editor is Clare Stone, who replaced the previous chief editor, Larry Peiperl, in 2018.

The American Medical Writers Association (AMWA) is a professional association for medical communicators, with more than 4,000 members in the United States, Canada, and 30 other countries. AMWA is governed by a board of directors composed of the elected officers, 6–8 at-large directors, and the chapter advisory council chair. AMWA has regional chapters and provides local networking opportunities throughout the United States and Canada. The association was founded in 1940 by physicians interested in improving the quality of medical writing and editing. The current president is Gail Flores, PhD.

<span class="mw-page-title-main">ICMJE recommendations</span>

The ICMJE recommendations are a set of guidelines produced by the International Committee of Medical Journal Editors for standardising the ethics, preparation and formatting of manuscripts submitted to biomedical journals for publication. Compliance with the ICMJE recommendations is required by most leading biomedical journals. Levels of real compliance are subject to debate. As of 9 January 2020, 5570 journals worldwide claim to follow the ICMJE recommendations.

The Vancouver system, also known as Vancouver reference style or the author–number system, is a citation style that uses numbers within the text that refer to numbered entries in the reference list. It is popular in the physical sciences and is one of two referencing systems normally used in medicine, the other being the author–date, or "Harvard", system. Vancouver style is used by MEDLINE and PubMed.

Pharmaceutical publication planning is the activity of planning the dissemination of scientific and clinical data on a drug to healthcare professionals at scientific congresses and medical society meetings and in peer reviewed medical journals.

Academic authorship of journal articles, books, and other original works is a means by which academics communicate the results of their scholarly work, establish priority for their discoveries, and build their reputation among their peers.

The Drug Industry Documents Archive (DIDA) is a digital archive of pharmaceutical industry documents created and maintained by the University of California, San Francisco, Library and Center for Knowledge Management. DIDA is a part of the larger UCSF Industry Documents Library which includes the Truth Tobacco Industry Documents. The archive contains documents about pharmaceutical industry clinical trials, publication of study results, pricing, marketing, relations with physicians and drug company involvement in continuing medical education.

The Grey Literature International Steering Committee (GLISC) was established in 2006 after the 7th International Conference on Grey Literature (GL7) held in Nancy (France) on 5–6 December 2005.

EASE Guidelines for Authors and Translators of Scientific Articles to be Published in English were first published by the European Association of Science Editors (EASE) in 2010. Updated versions are periodically released at the EASE Guidelines page of the EASE website. EASE Guidelines summarize the most important editorial recommendations, aiming to make international scientific communication more efficient and to aid in preventing scientific misconduct. They also support the global initiative Healthcare Information For All by 2015 by advising authors to make abstracts of their papers highly informative, reliable, and easily understandable. The document has been translated into many languages to facilitate its popularization worldwide and help scientists from non-Anglophone countries.

<span class="mw-page-title-main">Wyeth</span> American pharmaceutical company

Wyeth was a pharmaceutical company until it was purchased by Pfizer in 2009. The company was founded in Philadelphia, Pennsylvania, in 1860 as John Wyeth and Brother. Its headquarters moved to Collegeville, Pennsylvania, and Madison, New Jersey, before its headquarters were consolidated with Pfizer's in New York City after the 2009 merger.

The rhetoric of health and medicine is an academic discipline concerning language and symbols in health and medicine. Rhetoric most commonly refers to the persuasive element in human interactions and is often best studied in the specific situations in which it occurs. As a subfield of rhetoric, medical rhetoric specifically analyzes and evaluates the structure, delivery, and intention of communications messages in medicine- and health-related contexts. Primary topics of focus includes patient-physician communication, health literacy, language that constructs disease knowledge, and pharmaceutical advertising. The general research areas are described below. Medical rhetoric is a more focused subfield of the rhetoric of science.

In medicine, a clinical study report (CSR) on a clinical trial is a document, typically very long, providing much detail about the methods and results of a trial. A CSR is a scientific document addressing efficacy and safety, not a sales or marketing tool; its content is similar to that of a peer-reviewed academic paper. Results of trials are usually reported in a briefer academic journal paper, but methodological flaws are often glossed over in the briefer paper.

<span class="mw-page-title-main">Conflicts of interest in academic publishing</span>

Conflicts of interest (COIs) often arise in academic publishing. Such conflicts may cause wrongdoing and make it more likely. Ethical standards in academic publishing exist to avoid and deal with conflicts of interest, and the field continues to develop new standards. Standards vary between journals and are unevenly applied. According to the International Committee of Medical Journal Editors, "[a]uthors have a responsibility to evaluate the integrity, history, practices and reputation of the journals to which they submit manuscripts".

In research, a paper mill is a "profit oriented, unofficial and potentially illegal organisation that produce and sell fraudulent manuscripts that seem to resemble genuine research."

References

  1. 1 2 3 Sismondo, Sergio (September 2007). "Ghost management: how much of the medical literature is shaped behind the scenes by the pharmaceutical industry?". PLOS Medicine. 4 (9): e286. doi: 10.1371/journal.pmed.0040286 . ISSN   1549-1676. PMC   1989751 . PMID   17896859.
  2. ↑ "AMWA Ethics FAQ". amwa.org. Archived from the original on 2013-07-16.
  3. ↑ "Recommendations — Defining the Role of Authors and Contributors". ICMJE.org.
  4. ↑ "Recommendations". ICMJE.org.
  5. ↑ "Journals Following the ICMJE Recommendations". ICMJE.org.
  6. ↑ "Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Publishing and Editorial Issues Related to Publication in Biomedical Journals: Corrections, Retractions and "Expressions of Concern"". ICMJE.org. International Committee of Medical Journal Editors. Archived from the original on 2013-03-30. Retrieved 2013-03-19.
  7. ↑ "Guidelines". publicationethics.org.
  8. ↑ Wager, Liz (2012). "What to do if you suspect redundant (duplicate) publication" (PDF). publicationethics.org. http://publicationethics.org/files/All%20Flowcharts%20English%2017%20July%202012.pdf
  9. ↑ World Association of Medical Editors (June 2005). "Ghost writing initiated by commercial companies". Journal of General Internal Medicine. 20 (6): 549. doi:10.1111/j.1525-1497.2005.41015.x. ISSN   1525-1497. PMC   1490135 . PMID   15987333.{{cite journal}}: |last= has generic name (help)CS1 maint: date and year (link)
  10. ↑ Rennie, D.; Flanagin, A. (1994). "Authorship! Authorship! Guests, ghosts, grafters, and the two-sided coin". JAMA . 271 (6): 469–471. doi:10.1001/jama.1994.03510300075043. PMID   8295324.
  11. ↑ Studdert; et al. (2004). "Financial Conflicts of Interest in Physicians' Relationships with the Pharmaceutical Industry—Self-Regulation in the Shadow of Federal Prosecution". NEJM . 351 (18): 1891–1900. doi:10.1056/NEJMlim042229. PMID   15509824.
  12. ↑ Mathews, Anna Wilde (December 13, 2005). "At medical journals, paid writers play big role". Wall Street Journal .
  13. ↑ Ross, Elliot (20 May 2000). "How drug companies' PR tactics skew the presentation of medical research". The Guardian .
  14. ↑ House of Commons Health Committee (2005) The influence of the pharmaceutical industry. London: The Stationery Office Limited.
  15. 1 2 3 "Frequently Asked Questions about Medical Ghostwriting". Project On Government Oversight . June 28, 2011.
  16. ↑ Project On Government Oversight, "Frequently Asked Questions about Medical Ghostwriting", June 28, 2011
  17. ↑ Boseley, Sarah (February 7, 2002). "Scandal of scientists who take money for papers ghostwritten by drug companies". The Guardian . p. 4.
  18. ↑ Giombetti (1992). "UW's Friendly Corporate Ghostwriter". Eat the State. 6 (19).[ page needed ]
  19. ↑ Krimsky, Sheldon (2003). Science in the Private Interest: Has the Lure of Profits Corrupted Biomedical Research? . Lanham: Rowman-Littlefield. ISBN   0-7425-1479-X.
  20. ↑ Thacker, Paul, "How Scientific Literature Has Become Part of Big Pharma's Marketing Machine and How Being Nice Hurts Canada: 5 Questions with Ghostwriting Expert Trudo Lemmens", Project On Government Oversight, Jun 22, 2011
  21. ↑ Leo, J., and Lacasse, J.R. (2011) Why Does Academic Medicine Allow Ghostwriting: A Prescription for Reform. Society. Vol.
  22. ↑ Wilson, Duff; Singer, Natasha (September 11, 2009). "Ghostwriting Is Called Rife in Medical Journals". The New York Times. Retrieved May 12, 2010.
  23. ↑ Singer, Natasha (August 5, 2009). "Ghostwriters Paid by Wyeth Aided Its Drugs - NYTimes.com". The New York Times. Retrieved May 12, 2010.
  24. ↑ Jacobs, A.; Hamilton, A. (2009). "Decreased evidence of ghostwriting in a 2008 vs 2005 survey of medical writers" (PDF). The Write Stuff. 18 (2): 118–123. Archived from the original (PDF) on 2011-07-16. Retrieved 2010-02-23.
  25. ↑ "Ghostwriter werden → jetzt bewerben | Business and Science".
  26. ↑ Grassley, Charles, ed. (June 24, 2010). "Ghostwriting in Medical Literature" (PDF). Minority Staff Report,111th Congress, United States Senate Committee on Finance. Washington, DC. Retrieved 2010-07-11.{{cite book}}: CS1 maint: location missing publisher (link)

Further reading

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.